US STARTUP CHARGING COUPLES TO ‘SCREEN EMBRYOS FOR IQ'

Summary from the TLDR newsletter

Heliospect Genomics is a US startup that offers embryo screening services. The company allows couples to rank up to 100 embryos based on IQ, section, height, risk of obesity, risk of mental illness, and other traits. Its services cost up to $50,000. The company's offers represent an ethical minefield. Selecting embryos based on predicted IQ is legal in the US, but not in some other countries like the UK.